J&J’s COVID-19 vaccine candidate prevents severe disease in hamsters

J&J's COVID-19 vaccine candidate prevents severe disease in hamsters

Johnson & Johnson said its experimental coronavirus vaccine prevented hamsters from getting severely ill.

In the pre-clinical study, vaccinated animals lost less weight and had less virus in their lungs and other organs than unvaccinated animals.

The company began early-stage human trials in the United States and Belgium in July. Hamsters were first vaccinated and then exposed to coronavirus after four weeks.

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn

multimedia

news